Riastap vials
Ended Awarded
- Contract number
- SPE2DX25F6AGB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,878
Award facts
- Contract value 100% obligated
- $4,877.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award for RIASTAP Vials valued at $4,877.85 from the Defense Logistics Agency's Medical Supply Chain division on September 15, 2025. The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the issuance of delivery orders for pharmaceutical products supporting military health facilities worldwide.
RIASTAP is a fibrinogen concentrate used for treating fibrinogen deficiency in surgical and trauma settings. DMS Pharmaceutical Group's established position as a critical supplier in the federal pharmaceutical supply chain, combined with its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables, makes it well-positioned to fulfill this specialized pharmaceutical requirement. The company's continued success in securing delivery orders through the DLA's SPE2DB program underscores its role in ensuring reliable access to essential pharmaceutical products across Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DX25F6AGB?
SPE2DX25F6AGB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 15, 2025.
How much is contract SPE2DX25F6AGB worth?
The government has obligated $4,878 on SPE2DX25F6AGB.
Is contract SPE2DX25F6AGB an order under another contract?
Yes. SPE2DX25F6AGB is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGB competed?
The extent of competition for SPE2DX25F6AGB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award